Jeffrey Tomlinson

Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve.

Cogenics Icoria, Inc. provides medical research services. The firm offers genomics and proteomics-related research instruments, consumables, data, including databases, software & other research-oriented products. Icoria offers gene expression analysis and other related services. Its tissue informatics software performs tissue analysis for toxicology studies of early-stage drug candidates and other purposes. The firm also provides biomarkers to develop diagnostics and therapies for liver injuries, metabolic conditions & cancer. The company is headquartered in Research Triangle Park, NC.

NetGenics, Inc. develops software solutions for life science research. The firm provides bioinformatics solutions including the use of information technology by life science research companies to convert massive amounts of data into useful information that their scientists can then use in the development of new drugs, gene therapies, and agricultural products. The company was founded in 1996 and is headquartered in Cleveland, OH.

Working Opportunity Fund (EVCC) Ltd seeks investment opportunities in companies located in British Columbia (Canada). The fund targets companies operating in the fields of information technology, life sciences, and clean technologies. It provides financing for early and later stage capital requirements.

Xceed Molecular Corporation is a molecular diagnostic company dedicated to commercializing a platform for automated gene expression analysis and developing proprietary clinical research assays and custom arrays. They develop tools and content aimed at accelerating the current market trend towards 'translational medicine', and bridging the gap from gene signature validation to clinical diagnostics. The Ziplex Automated Workstation is the first integrated and fully automated hybridization system for multiplex gene expression signatures. Their integrated solution - the Ziplex System - features this innovative instrument platform and focused-content TipChip arrays and reagents to perform highly multiplexed molecular assays with superior accuracy, reproducibility, speed and scalability. The Ziplex System is designed to provide the ease-of-use in assay automation and analytics that is required to successfully translate gene expression analysis from research use into routine practice. Xceed complements the Ziplex platform by offering Gene Expression Services and Assay Development Services.

BDC Venture Capital (BDC Venture Capital) is a venture capital firm founded in 1975. The firm is headquartered in Québec, Canada.

GenoLogics Life Sciences Software, Inc. provides laboratory information management system software. Its products include tools for genomics, proteomics, biorepositories, and laboratories. The firm’s product, Clarity LIMS, is used for clinical and research labs that provide next generation sequencing and genomics services. Its services encompass customer support, technical, project and implementation management, and training. The company was founded by Jonathan Kerr and James Degreef in 2002 and is headquartered in Victoria, Canada.

3659992 Canada, Inc. provides desktop collaboration technology. The firm operates in area of oil and gas, architecture, engineering and construction, law firms and legal departments and government. The company was founded by Barry W. Jinks in April 2000 and is headquartered in Vancouver, BC.

Teradici Corp. develops technology and solutions for personal computer over internet protocol networks. Its technology is deployed throughout virtual and cloud environments, in zero clients, hardware accelerators, standalone workstations and mobile devices. The firm technology for creating virtual workspaces and powers the spectrum of local, remote, mobile, collaborative workstyles, fundamentally simplifying how computing is provisioned, managed and used throughout virtual and cloud environments. The company was founded by Daniel Keith Cordingley, Fahmi Maher, Hobbs David and Ken Unger in 2004 and is headquartered in Burnaby, Canada.

Pender Private Equity Fund Management Inc (Pender Ventures) is a venture capital subsidiary of PenderFund Capital Management Ltd founded in 1994 by John Kelly Edmison. The firm is headquartered in Vancouver, Canada with an office in Ontario.

Shoreline Venture Management LLC (Shoreline Venture Management) is a venture capital firm founded in 1998 by Peter Craddock and Robert S. Spears. The firm is headquartered in San Francisco, California.

Redlen Technologies, Inc. engages in the manufacture of resolution Cadmium Zinc Telluride semiconductor radiation detectors. It enables performance detection and imaging equipment including Nuclear Cardiology, CT Scanning, Baggage Scanning and Dirty Bomb Detection. The company was founded in November 1999 and is headquartered in Saanichton, Canada.

Global Brands Group Pte Ltd. provides product licensing, brand management, and retail development services. The firm offers services for sports, entertainment, and lifestyle brands. Its brand partners include PGA TOUR, FIBA, FIFA, Playground Productions, Chorion, Evisu, and IPC Media. The firm also operates in Asia, Australasia, Europe, Middle East, North & South America, and South Africa. The company was founded in September 2003 by David St. George and Jonathan Sieff and is headquartered in Singapore City, Singapore.

Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE.

GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA.

Librestream Technologies, Inc. engages in the development of onsight mobile collaboration solutions. It provides a visual collaboration solution that allows enterprises to remotely view, diagnose, consult and resolve issues in real time. The company was founded by Kerry Thacher in 2003 and is headquartered in Winnipeg, Canada.

QuickMobile, Inc. provides mobile applications and solutions for meetings and events. It offers mobileplanner, which allows the user to plan and manage multiple events by collaborating, communicating, and sharing events and meetings across the organization; mobilevenue, a mobile application that displays information about maps, schedules, and directory of on-site and nearby amenities and attractions; and Concerto, a social media tracking and sharing platform. The company was founded by Patrick Payne, Gautam Lohia, and Jim Udall in 2006 and is headquartered in Vancouver, Canada.

ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore.

Beedie Capital Partners is a private equity subsidiary of Beedie Development Group founded in 2010 . The firm is headquartered in Burnaby, British Columbia with offices in Vancouver, Calgary and Toronto.

Terramera, Inc. manufactures pesticides and agrochemicals products. It offers biopesticides for the control of bed bugs and other household pests, biopesticides for agricultural use in a variety of crops and applications for bee health, cold pressed neem oil, neem cake, karanja oil, karanja cake, and other ecologically friendly products for use in agriculture, human health, and cosmetic applications; and other professional products. The company was founded by Karn Manhas and is headquartered in Vancouver, Canada.

Jane Software, Inc. operates as a cloud-based clinic management software company. Its software offers allied health clinics online bookings, charting, scheduling, and invoicing. The company was founded by Alison Taylor and Trevor Johnston in 2011 and is headquartered in North Vancouver, Canada.

Clarius Mobile Health Corp. develops novel medical imaging ecosystem. It specializes in primary care. veterinary, anesthesia, interventional, and pain management. The company was founded by Laurent Pelissier and David G. Willis in 2014 and is headquartered in Burnaby, Canada.

Oak Hill Bio, Inc. is a clinical-stage rare disease therapeutics company. It develops life-changing medicines for extremely preterm infants and patients suffering from rare autoimmune diseases. The firm has operations in the United States and United Kingdom to develop a pipeline of clinical-stage and pre-clinical investigational therapeutics acquired and licensed from Takeda Pharmaceutical Company Limited. The company is headquartered in Cambridge, MA.

Dotbio Pte Ltd. was founded in 2017 and is based in Singapore, Singapore. The Singaporean company takes an innovative therapeutic approach towards the ideal treatment by rapidly prototyping multi-functional antibodies to identify molecules with synergistic activity combinations, optimal architectures, and unique mechanisms of action. Dotbio's approach involves the use of its modular dotbody technology platform, its cofi and hot-cofi stabilization technologies, high-throughput miniaturized assays, and data analytics to generate unique therapeutic molecules that target both extracellular and intracellular disease drivers. Dotbio has a pipeline of such molecules.